'Market nirvana': JPMorgan says the S&P 500 will surge another 11% by early 2021 as the market faces its best backdrop in years

Advertisement
'Market nirvana': JPMorgan says the S&P 500 will surge another 11% by early 2021 as the market faces its best backdrop in years
Reuters / John Gress
  • President-elect Joe Biden's victory and a divided Congress form a "market nirvana" scenario for investors, JPMorgan strategists said Monday.
  • In a note to clients, the team lifted its S&P 500 target for early 2021 to 4,000, implying a roughly 11% rally from current levels.
  • While Biden is likely to push for additional fiscal stimulus, Senate Republicans would block market-adverse policies like tax hikes and stricter regulations, JPMorgan said.
  • The new target could be nullified if Democrats win both runoff elections in Georgia and take control of the Senate, the team added.
  • Visit Business Insider's homepage for more stories.
Advertisement

After bouts of market turbulence driven by the pandemic, US-China trade tensions, and election uncertainties, stocks are on track for a sustained rally, JPMorgan said Monday.

The bank's market outlook "is significantly clearing up," strategists led by Dubravko Lakos-Bujas said in a note to clients. The firm said President-elect Joe Biden's victory and a split Congress made for a "market nirvana" scenario where Senate Republicans can block tax increases and stricter regulations sought by Democrats while Biden pushes for new stimulus.

JPMorgan also expects the Federal Reserve's extremely supportive monetary-policy stance to further bolster stock valuations. To that end, the firm expects the S&P 500 to reach 3,600 by the end of the year and continue climbing to 4,000 by early 2021. The latter target implies a roughly 11% climb from current levels.

Read more: Morgan Stanley says to load up on these 10 stocks featured on the firm's 'buy list,' which has dominated the broader market this year

The year-end target was reached on Monday as stocks climbed higher. Major indexes surged after Pfizer announced its coronavirus vaccine candidate was found to be more than 90% effective at preventing COVID-19 in trials. The pharmaceutical giant said it planned to apply for emergency use authorization to more rapidly distribute the drug.

Advertisement

The runoff elections for Georgia's two Senate seats present the most significant short-term risk, the bank said. Democratic victories would create a blue-wave election outcome and form a government controlled by Democrats. That "would pose downside risk" by negating the divided-government scenario deemed ideal by the strategists. The risk is likely overstated, the team added, since Republicans are largely expected to win at least one of the seats.

Read more: From flipping burgers at McDonald's to a self-made multimillionaire: How Willie Mandrell leveraged a simple real-estate investing strategy to acquire 40 units and achieve financial freedom

Investors looking for the best way to position for the market upswing should look to the value stocks beaten down by the coronavirus pandemic. Growth stocks — particularly mega-cap tech firms — led the market's rebound through the summer and continue to trade at heightened valuations. A sturdy economic recovery should pull investor capital from momentum stocks and into value names as their earnings bounce back, the team said.

"The backdrop of globally synchronized expansion, legislative gridlock, and positive vaccine news should mark a breakout point for value stocks," the strategists said.

Now read more markets coverage from Markets Insider and Business Insider:

Advertisement

3 volatility experts explain why the VIX has plunged so quickly despite a nail-biting election contest — and share what they are recommending to clients right now

US GDP will be back to pre-pandemic levels by mid-2021 under a Biden presidency and as vaccine progress continues, Goldman says

Airline and cruise stocks rally as Pfizer drug progress spurs hope for travel-industry recovery

{{}}